IQVIA Holdings Inc. (0JDM.L)

USD 147.96

(3.19%)

Eps Summary of IQVIA Holdings Inc.

  • IQVIA Holdings Inc.'s latest annual eps in 2023 was 7.39 USD , up 26.98% from previous year.
  • IQVIA Holdings Inc.'s latest quarterly eps in 2024 Q3 was 1.57 USD , down -21.11% from previous quarter.
  • IQVIA Holdings Inc. reported an annual eps of 5.82 USD in 2022, up 15.25% from previous year.
  • IQVIA Holdings Inc. reported an annual eps of 5.05 USD in 2021, up 245.89% from previous year.
  • IQVIA Holdings Inc. reported a quarterly eps of 1.58 USD for 2024 Q1, down -38.76% from previous quarter.
  • IQVIA Holdings Inc. reported a quarterly eps of 1.99 USD for 2024 Q2, up 25.95% from previous quarter.

Annual Eps Chart of IQVIA Holdings Inc. (2023 - 2010)

Historical Annual Eps of IQVIA Holdings Inc. (2023 - 2010)

Year Eps Eps Growth
2023 7.39 USD 26.98%
2022 5.82 USD 15.25%
2021 5.05 USD 245.89%
2020 1.46 USD 48.98%
2019 0.98 USD -22.83%
2018 1.27 USD -78.87%
2017 6.01 USD 680.52%
2016 0.77 USD -75.56%
2015 3.15 USD 13.31%
2014 2.78 USD 51.91%
2013 1.83 USD 28.87%
2012 1.42 USD -26.42%
2011 1.93 USD 50.78%
2010 1.28 USD 0.0%

Peer Eps Comparison of IQVIA Holdings Inc.

Name Eps Eps Difference
Thermo Fisher Scientific Inc. 15.53 USD 52.415%
Dynavax Technologies Corporation -0.05 USD 14999.194%
Illumina, Inc. -7.35 USD 200.544%
Biogen Inc. 8.02 USD 7.855%
Iovance Biotherapeutics, Inc. -1.89 USD 491.005%
Mettler-Toledo International Inc. 36.10 USD 79.529%
Sarepta Therapeutics, Inc. -5.80 USD 227.414%
Supernus Pharmaceuticals, Inc. 0.02 USD -30563.9%
Waters Corporation 10.87 USD 32.015%
Perrigo Company plc -0.09 USD 7970.075%
uniQure N.V. -6.47 USD 214.219%
Agios Pharmaceuticals, Inc. -6.33 USD 216.746%
Amicus Therapeutics, Inc. -0.51 USD 1549.02%
Atara Biotherapeutics, Inc. -65.18 USD 111.338%
bluebird bio, Inc. -1.93 USD 482.902%
Cara Therapeutics, Inc. -2.19 USD 437.443%
Imunon, Inc. -2.16 USD 442.13%
Myriad Genetics, Inc. -1.39 USD 631.655%
Neurocrine Biosciences, Inc. 2.56 USD -188.672%
Nektar Therapeutics -1.45 USD 609.655%
Editas Medicine, Inc. -2.02 USD 465.842%
Verastem, Inc. -3.96 USD 286.616%
Walgreens Boots Alliance, Inc. -10.01 USD 173.826%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 171.678%
Heron Therapeutics, Inc. -0.80 USD 1023.75%
Unity Biotechnology, Inc. -2.70 USD 373.704%
BioMarin Pharmaceutical Inc. 0.89 USD -730.337%
Sangamo Therapeutics, Inc. -1.48 USD 599.324%
Evolus, Inc. -1.08 USD 784.259%
Adicet Bio, Inc. -3.31 USD 323.263%
Aclaris Therapeutics, Inc. -1.27 USD 681.89%
Regeneron Pharmaceuticals, Inc. 37.05 USD 80.054%
Esperion Therapeutics, Inc. -2.03 USD 464.039%
FibroGen, Inc. -2.92 USD 353.082%
Agilent Technologies, Inc. 4.22 USD -75.118%
OPKO Health, Inc. -0.25 USD 3056.0%
Homology Medicines, Inc. -7.41 USD 199.73%
Geron Corporation -0.32 USD 2409.375%
Alnylam Pharmaceuticals, Inc. -3.52 USD 309.943%
Exelixis, Inc. 0.65 USD -1036.923%
Viking Therapeutics, Inc. -0.91 USD 912.088%
Anavex Life Sciences Corp. -0.60 USD 1331.667%
Intellia Therapeutics, Inc. -5.42 USD 236.347%
Zoetis Inc. 5.08 USD -45.472%
Axsome Therapeutics, Inc. -5.27 USD 240.228%
Abeona Therapeutics Inc. -2.53 USD 392.095%
Vertex Pharmaceuticals Incorporated 14.05 USD 47.402%
Kala Pharmaceuticals, Inc. -17.35 USD 142.594%
Ionis Pharmaceuticals, Inc. -2.56 USD 388.672%
Corcept Therapeutics Incorporated 1.02 USD -624.51%
Halozyme Therapeutics, Inc. 2.13 USD -246.948%
Blueprint Medicines Corporation -8.37 USD 188.292%
Insmed Incorporated -5.34 USD 238.39%
TG Therapeutics, Inc. 0.09 USD -8175.476%
Incyte Corporation 2.67 USD -176.779%
Emergent BioSolutions Inc. -14.85 USD 149.764%